KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity. (2022)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.2101139
PubMed Identifier: 35768150
Publication URI: http://europepmc.org/abstract/MED/35768150
Type: Journal Article/Review
Volume: 209
Parent Publication: Journal of immunology (Baltimore, Md. : 1950)
Issue: 2
ISSN: 0022-1767